Leticia Bueno
Grupo de investigación
- Investigación aplicada en infecciones respiratorias y enfermo crítico Pre-doctoral researcher (R1)
Publicaciones destacadas
-
Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with Bronchiectasis
Autores:Referencia: Journal Of Antimicrobial Chemotherapy (Jac) 2022. -
[Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.]
Autores:Referencia: Archivos De Bronconeumologia 2022. -
Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation
Autores:Referencia: Analytical Chemistry 2022. -
Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year
Autores:Referencia: Journal Of Clinical Medicine 2021. -
Characteristics and Outcomes in Patients with Ventilator-Associated Pneumonia Who Do or Do Not Develop Acute Respiratory Distress Syndrome
Autores:Referencia: Journal Of Clinical Medicine 2020. -
SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas Exchange Abnormalities
Autores:Referencia: Annals Of The American Thoracic Society 2020. -
Assessment of a Loop-Mediated Isothermal Amplification (LAMP) Assay for the Rapid Detection of Pathogenic Bacteria from Respiratory Samples in Patients with Hospital-Acquired Pneumonia
Autores:Referencia: Microorganisms 2020. -
Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
Autores:Referencia: Journal Of Clinical Medicine 2019. -
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia
Autores:Referencia: Chest 2019.
Proyectos destacados
-
ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (ECMOCARD)
Financiador: The University of Queensland (Promotor)Código: ECMOCARDDuración: 16/03/2020 -
Fenotipos relacionados con la evolución clínica a corto y largo plazo en la NAC
Financiador: Fondo Investigaciones Sanitarias (FIS)Instituto de Salud Carlos III (Programa financiador competitivo); Fondo Investigaciones Sanitarias (FIS) (Programa financiador competitivo); Instituto de Salud Carlos III ; Hospital Clinic Barcelona (Sede o evento)Código: PI19/00207Duración: 01/01/2020 -
Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia (HAP2)
Investigador/a principal: Antoni Torres, Laia (Coordinador/a gerente) Fernández BaratFinanciador: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); H2020, European Comission (Programa financiador competitivo)Código: CE-H2020-SC1-2019-2sDuración: 01/01/2020 - 01/01/2024 -
Risk factors, personalized prognosis and one-year follow-up of patients admitted to Spanish Intensive Care units infected with the COVID19 virus: CIBERESUCICOVID
Investigador/a principal: Laia Fernandez BaratFinanciador: CIBER ENFERMEDADES RESPIRATORIAS (CIBERES) (Sede o evento); Instituto Carlos III, ISCIIICódigo: COV20/00110Duración: 01/01/2020 - 01/01/2021 -
Role of Pseudomonas aeruginosa biofilms in exacerbations in patients with bronchiectasis with and without Chronic Obstructive Pulmonary Disease
Investigador/a principal: Laia Fernández BaratFinanciador: CIBER ENFERMEDADES RESPIRATORIAS (CIBERES) (Sede o evento)Duración: 01/01/2019 - 01/01/2020